Clinical Trial Update: A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II study evaluating radiation therapy with paclitaxel poliglumex and cetuximab in advanced head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Squamous Cell
• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Paclitaxel poliglumex (paclitaxel poliglumex)
• Radiation therapy

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Carcinoma, Squamous Cell | Phase 1, Phase 2 | Status: COMPLETED